About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Trials for Shorter TB Treatment Undertaken in South Africa

by Kathy Jones on March 31, 2012 at 8:51 PM
Font : A-A+

 Trials for Shorter TB Treatment Undertaken in South Africa

Medical trials to shorten the duration of tuberculosis treatment that would make it easier for patients to complete the full regimen will be conducted shortly, South African researchers have said.

"Fighting tuberculosis is going to require new strategies. The ongoing trial aimed at reducing the treatment period from six to four months is one of the new strategies of fighting the disease," said Gavin Churchyard, chief executive of Aurum Institute, an independent medical research body.

Advertisement

"South Africa has the highest burden of TB infections (in the world), therefore it is important to position ourselves in the forefront of new research to help stop the disease," he said.

The trials are conducted at the TB Research Centre, based at a public hospital in Tembisa township east of Johannesburg, one of the areas with the highest infection rates.
Advertisement

Aurum has also partnered with the French pharmaceutical firm Sanofi to increase research capacity in various TB initiatives.

"No organisation can work alone to make a meaningful contribution towards eliminating the disease," said Christopher Viehbacher, chief executive of Sanofi.

"The long period of treatment has been identified as one of the reasons for poor adherence, resulting in drug resistant TB strains, which are more expensive to treat," he said.

This month, TB Alliance in Washington unveiled plans for the first clinical tests of a new treatment regimen for tuberculosis that could shorten treatment times to four months in both patients with TB and some forms of drug-resistant TB.

Many TB patients fail to complete treatment because they cannot tolerate the difficult side effects of the medications or cannot adhere to the long-term treatment, according to the TB Alliance.

This leads to drug resistant forms of the disease, or even extensively drug-resistant TB known as XDR-TB.

A total of 8.8 million people worldwide fell ill with the contagious lung disease in 2010 and around 1.4 million died, according to the World Health Organization (WHO).

Source: AFP
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Test  Your Knowledge on Heart
Test Your Knowlege on Genes
Obesity in Teens Make Inroads into Early Atrial Fibrillation
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Tuberculosis AIDS/HIV Silicosis Screening Tests for Tuberculosis 

Most Popular on Medindia

Drug Interaction Checker Selfie Addiction Calculator Drug Side Effects Calculator Calculate Ideal Weight for Infants Nutam (400mg) (Piracetam) Daily Calorie Requirements Post-Nasal Drip The Essence of Yoga Color Blindness Calculator Loram (2 mg) (Lorazepam)
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Trials for Shorter TB Treatment Undertaken in South Africa Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests